← Leaderboards
Thuy A Doan
University Of California, San Francisco
$5,287,003
Attributed
$5,728,516
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,728,516 · 5
By mechanism
R01$4,082,290 · 3
K08$1,195,226 · 1
R21$451,000 · 1
Top collaborators
- Nisha Acharya2 shared
- Jessica Shantha1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Michael R Wilson$8,552,789
- Catherine Elizabeth Oldenburg$6,320,431
- Samuel Jeremy Pleasure$23,213,386
- Nisha Acharya$16,289,853
- Mark S Anderson$96,401,564
Others in their field
Top investigators on “Etiology”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$170,427,232
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$111,262,717
- Lloyd D Johnston · University Of Michigan At Ann Arbor$86,877,240
- James E. Gern · University Of Wisconsin-Madison$82,846,335
- William J. Blot · Vanderbilt University$68,004,179
- Daniel H Geschwind · University Of California Los Angeles$55,345,131
Research focus
EtiologySamplingPathogenDiagnosticOrganismPreventDeep SequencingPathogenesisDetectionImmune ResponseGenomicsFutureTechnologyInfectionBlindnessVisualMorbidity - Disease RateCollaborationsFoundationsSeasonsDiagnostic TestsGene Expression ProfileInfectious AgentFungus
Grant awards (17)
Multi-omics Strategies to Improve Clinical Outcomes in Uveitis$432,027
R01 · FY2025 · EY
Improving Corneal Ulcer Outcomes with Unbiased Pathogen and Antimicrobial Resistance Detection$407,641
R01 · FY2025 · EY · contact PI
Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)$404,861
R01 · FY2025 · EY · contact PI
Programmable Phage Display Peptidomes to Characterize Uveitis$205,000
R21 · FY2025 · EY · contact PI
Improving Corneal Ulcer Outcomes with Unbiased Pathogen and Antimicrobial Resistance Detection$407,641
R01 · FY2024 · EY · contact PI
Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)$404,861
R01 · FY2024 · EY · contact PI
Programmable Phage Display Peptidomes to Characterize Uveitis$246,000
R21 · FY2024 · EY · contact PI
Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)$404,861
R01 · FY2023 · EY · contact PI
Improving Corneal Ulcer Outcomes with Unbiased Pathogen and Antimicrobial Resistance Detection$403,750
R01 · FY2023 · EY · contact PI
Improving Corneal Ulcer Outcomes with Unbiased Pathogen and Antimicrobial Resistance Detection$403,750
R01 · FY2022 · EY · contact PI
Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)$394,376
R01 · FY2022 · EY · contact PI
Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)$418,522
R01 · FY2021 · EY · contact PI
Ocular Surface Microbiome, Virome, and Pathogens in Ophthalmic Disease and Health$239,059
K08 · FY2020 · EY · contact PI
Ocular Surface Microbiome, Virome, and Pathogens in Ophthalmic Disease and Health$239,059
K08 · FY2019 · EY · contact PI
Ocular Surface Microbiome, Virome, and Pathogens in Ophthalmic Disease and Health$239,059
K08 · FY2018 · EY · contact PI
Ocular Surface Microbiome, Virome, and Pathogens in Ophthalmic Disease and Health$238,990
K08 · FY2017 · EY · contact PI
Ocular Surface Microbiome, Virome, and Pathogens in Ophthalmic Disease and Health$239,059
K08 · FY2016 · EY · contact PI